A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer
February 22, 2024
February 22, 2024
NEW YORK, Feb. 22 (TNSres) -- Mount Sinai Hospital issued the following news release on Feb. 21, 2024:
* * *
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
* * *
A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial l . . .
* * *
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
* * *
A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial l . . .